RGEN Repligen Corporation

163.81USD-3.81%Mkt Cap: 10.47B USDP/E: —

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fib…